Abstract:
Urinary incontinence (UI) is being perceived as a stigmatized condition since ancient times. Not much has changed up to date – although, posing a considerable disease burden and impairing health related quality of life-urinary incontinence (HRQOL- UI) is not perceived as a medical entity by adult females in Turkey, and -due to lack of medical help seeking- probably is underreported. Overall prevalence in Turkey has been reported to be between 16.4 and 68.8%, depending on research setting and methodology. Because HRQOL is a new concept in medical research, there are only few urinary incontinence (UI) studies addressing quality of life (QOL), as well. The studies assessing QOL of individuals with UI are mostly cross-sectional and -except for the recent ones- do not use grade A International Consultation on Incontinence (ICI) recommended instruments. This chapter summarizes the available instruments used for diagnosis, classification and severity grading, as well HRQOL assessment. According to the results of studies on UI and related QOL, the disease burden and bothersomeness created by the condition is impairing QOL and mostly is the determinant for medical help seeking behavior, which is displaying a transcultural trend being in accordance with the world literature. There is a need for a clearinghouse for studies on UI and related QOL to plan and conduct such studies, manage and organize dissemination of evidence, and take action according to health policy needs in that matter.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Abbreviations
- BFLUTS:
-
Bristol female lower urinary tract symptoms questionnaire
- DIS:
-
Detrusor instability score
- HRQOL:
-
health related quality of life
- ICI:
-
International Consultation on Incontinence
- ICIQ-SF:
-
International Consultation on Incontinence Questionnaire Short Form
- ICS:
-
International continence society
- ICSmale-LUTS:
-
International Consultation on Incontinence Questionnaire lower urinary tract symptoms
- IIQ:
-
incontinence impact questionnaire
- I-QOL:
-
incontinence QOL instrument
- IQOLI:
-
incontinence QOL index
- ISI:
-
incontinence severity index
- KHQ:
-
King’s Health Questionnaire
- LUTS:
- MUI:
- OAB:
- PRAFAB:
-
protection, amount, frequency, adjustment, body image
- QOL:
-
quality of life
- RCT:
-
randomized controlled trial
- SF-36:
-
medical outcomes study (MOS) 36-item short-form health survey (SF-36)
- SII:
-
symptom impact index
- SSI:
-
symptom severity index
- SUI:
- SUIQQ:
-
stress urinary incontince quality of life questionnaire
- UDI:
-
urogenital distress inventory
- UI:
-
urinary incontinence
- UUI:
- WHO:
-
World Health Organization
References
Abrams P, Cardozo L, Fall M, Griffiths D, Rosier P, Ulmsten U, van Kerrebroeck P, Victor A, Wein A. (2002a). Neurourol Urodyn. 21: 167–178.
Abrams P, Cardozo L, Fall M, Griffiths D, Rosier P, Ulmsten U, van Kerrebroeck P, Victor A, Wein A. (2002b). Am J Obstet Gynecol. 187: 116–126.
Aksakal OS, Gungor T, Karaer A, Ugurlu EN, Aral AM, Bilge U. (2006). J Turkish-German Gynecol Assoc. 7: 210–214.
Amarenco G, Arnould B, Carita P, Haab F, Labat JJ, Richard F. (2003). Eur Urol. 43: 391–404.
Aslan E, Beji NK, Coskun A, Yalcin O. (2003). Int Urogynecol J Pelvic Floor Dysfunct. 14: 316–319; discussion 320.
Ateskan U, Mas MR, Doruk H, Kutlu M. (2000). Turkish J Geriatrics. 3: 45–50.
Biri A, Durukan E, Maral I, Korucuoglu U, Biri H, Tyras B, Bumin MA. (2006). Int Urogynecol J Pelvic Floor Dysfunct. 17: 604–610.
Brocklehurst JC .(1993). BMJ. 306: 832–834.
Cam C, Sakalli M, Ay P, Cam M, Karateke A. (2007). Neurourol Urodyn. 26: 129–133.
Cetinel B, Demirkesen O, Tarcan T, Yalcin O, Kocak T, Senocak M, Itil I. (2007). Int Urogynecol J Pelvic Floor Dysfunct. 18: 659–664.
Cetinel B, Ozkan B, Can G. (2004). Turkish J Urol. 30: 332–338.
Cinar N, Topsever P, Uludag C, Gorpelioglu S, Aydin N, Filiz T. (2006). Diabet Med. 23(Suppl. 4): 168.
Ekin M, Karayalcin R. (2004). J Ankara Med School. 26: 21–25.
Filiz M, Topsever P, Cinar N, Uludag C, Gorpelioglu S, Aydin N. (2006a). Diabet Med. 23(Suppl. 4): 404.
Filiz TM, Topsever P, Uludag C, Gorpelioglu S, Cinar N. (2007). Turkiye Klinikleri J Med Sci. 27: 189–194.
Filiz TM, Uludag C, Cinar N, Gorpelioglu S, Topsever P. (2006b). Saudi Med J. 27: 1688–1692.
Gotoh M. (2007). Nagoya J Med. 69: 123–131.
Hannestad YS, Rortveit G, Sandvik H, Hunskaar S. (2000). J Clin Epidemiol. 53: 1150–1107.
Holst K, Wilson PD. (1988). N Z Med J. 101: 756–758.
Hunskaar S, Burgio K, Diokno A, Herzog AR, Hjalmas K, Lapitan MC. (2003). Urology. 62(Suppl. 1): 16–23.
Imamoglu A, Ozturk U, Eroglu M, Taygun C, Kiper A. (2005). Ankara Üniversitesi Tip Fakültesi Mecmuasi. 58: 1–4.
Jackson S, Shepherd A, Brookes S, Abrams P. (1999). Br J Obstet Gynaecol. 106: 711–718.
Karan A, Aksac B, Ayyildiz H, Isikoglu M, Yalcin O, Eskiyurt N. (2000). Turk J Geriatrics 3(3): 102–106.
Kelleher CJ, Cardozo LD, Khullar V, Salvatore S. (1997). Br J Obstet Gynaecol. 104: 1374–1379.
Kocak I, Okyay P, Dundar M, Erol H, Beser E. (2005). Eur Urol. 48: 634–641.
Lee PS, Reid DW, Saltmarche A, Linton L. (1995). J Am Geriatr Soc. 43: 1275–1278.
Maral I, Ozkardes H, Peskircioglu L, Bumin MA. (2001). J Urol. 165: 408–412.
Minassian VA, Drutz HP, Al-Badr A. (2003). Int J Gynaecol Obstet. 82: 327–338.
Moller LA, Lose G, Jorgensen T. (2000). Acta Obstet Gynecol Scand. 79: 298–305.
Onur R, Singla A, Kobashi KC. (2007). Int Urol Nephrol. 40(1): 45–49.
Oskay UY, Beji NK, Yalcin O. (2005). Acta Obstet Gynecol Scand. 84: 72–78.
Ozerdogan N, Beji NK, Yalcin O. (2004). Gynecol Obstet Invest. 58: 145–150.
Renck-Hooper U, McKenna SP, Whalley D. (1998). J Drug Assess. 1: 41–48.
Sandvik H, Hunskaar S, Seim A, Hermstad R, Vanvik A, Bratt H. (1993). J Epidemiol Community Health. 47: 497–499.
Seckiner I, Yesilli C, Mungan NA, Aykanat A, Akduman B. (2007). Neurourol Urodyn. 26: 492–494.
Shumaker SA, Wyman JF, Uebersax JS, McClish D, Fantl JA. (1994). Qual Life Res. 3: 291–306.
Sommer P, Bauer T, Nielsen KK, Kristensen ES, Hermann GG, Steven K, Nordling J. (1990). Br J Urol. 66: 12–15.
Swithinbank LV, Donovan JL, du Heaume JC, Rogers CA, James MC, Yang Q, Abrams P. (1999). Br J Gen Pract. 49: 897–900.
Topsever P, Filiz TM, Uludag C, Dede Cinar N. (2007). Diabetologia. 50(Suppl. 1): 470.
Turan C, Zorlu CG, Ekin M, Hancerliogullari N, Saracoglu F. (1996). Gynecol Obstet Invest. 41: 132–134.
Uebersax JS, Wyman JF, Shumaker SA, McClish DK, Fantl JA. (1995). Neurourol Urodyn. 14: 131–139.
Uemura S, Homma Y. (2004). Neurourol Urodyn. 23: 94–100.
van den Muijsenbergh ME, Lagro-Janssen TA. (2006). Br J Gen Pract. 56: 945–949.
Wagner TH, Patrick DL, Bavendam TG, Martin ML, Buesching DP. (1996). Urology. 47: 67–72.
Wall LL. (2003). Int Urogynecol J Pelvic Floor Dysfunct. 14: 67–69.
Yarnell JW, Voyle GJ, Richards CJ, Stephenson TP. (1981). J Epidemiol Community Health. 35: 71–74.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2010 Springer Science+Business Media LLC
About this entry
Cite this entry
Filiz, T.M., Topsever, P. (2010). Quality of Life and Age Urinary Incontinence Severity: Turkish Perspectives. In: Preedy, V.R., Watson, R.R. (eds) Handbook of Disease Burdens and Quality of Life Measures. Springer, New York, NY. https://doi.org/10.1007/978-0-387-78665-0_160
Download citation
DOI: https://doi.org/10.1007/978-0-387-78665-0_160
Publisher Name: Springer, New York, NY
Print ISBN: 978-0-387-78664-3
Online ISBN: 978-0-387-78665-0
eBook Packages: MedicineReference Module Medicine